"The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...

We have highlighted five of those — Merck & Co. Inc. MRK, Verizon Communications VZ, Johnson & Johnson JNJ, The Coca-Cola Company KO and Amgen AMGN ... which gauges both manufacturing and ...

In this article, we will look at the 11 Best Undervalued Stocks to Invest in Now.

Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...

This collaboration will foster innovation and pave the way for more resilient and adaptive communication networks ... IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS Amgen and Kyowa Kirin Co., Ltd ...

Syniverse, the world's most connected company®, has furthered its partnership with Limitless Mobile, a specialist mobile network operator (MNO) focused on enabling technically advanced mobile use ...

US equity indexes traded mixed after midday Monday amid declines in technology and communication services ... was little changed at 4.19%. In company news, Amgen (AMGN) will invest an initial ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on Radio-DARPins now expanded to ten programsMP0533 Phase 1/2 ...